91 related articles for article (PubMed ID: 6228462)
1. Hepatitis B vaccine: safety study in anti-HBs seropositive human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():223-7. PubMed ID: 6228462
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():229-35. PubMed ID: 6228463
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
[TBL] [Abstract][Full Text] [Related]
4. Safety and potency aspects in the preparation of an experimental HBsAg vaccine.
Thomssen R; Gerlich WH; Böttcher U; Legler K; Ritter S; Stibbe W; Weinmann W; Klinge O; Pfeifer U
Dev Biol Stand; 1983; 54():23-31. PubMed ID: 6228464
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
[TBL] [Abstract][Full Text] [Related]
6. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
Scheiermann N; Kuwert EK
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with recombinant HBsAg-HBIG complex in healthy adults.
Xu DZ; Huang KL; Zhao K; Xu LF; Shi N; Yuan ZH; Wen YM
Vaccine; 2005 Apr; 23(20):2658-64. PubMed ID: 15780449
[TBL] [Abstract][Full Text] [Related]
8. Kinetics, subtype specificity and immunoglobulin class of anti-HBs induced by hepatitis B vaccine.
Legler K; Strohmeyer H; Ritter S; Gerlich WH; Thomssen R
Dev Biol Stand; 1983; 54():179-89. PubMed ID: 6228457
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccine in developing countries: problems and prospects.
Ayoola EA
IARC Sci Publ; 1984; (63):297-305. PubMed ID: 6242148
[TBL] [Abstract][Full Text] [Related]
11. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
Rahman F; Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
Hepatology; 2000 Feb; 31(2):521-7. PubMed ID: 10655280
[TBL] [Abstract][Full Text] [Related]
12. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity to hepatitis B surface antigen in man.
Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
[TBL] [Abstract][Full Text] [Related]
14. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
Hu Y; Wu Q; Xu B; Zhou Z; Wang Z; Zhou YH
Vaccine; 2008 Nov; 26(48):6064-7. PubMed ID: 18812198
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
[TBL] [Abstract][Full Text] [Related]
16. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
Zhang FM; Zhao QX; Han JH; Zhou QH; Wang MC; Miao W; Li R
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):697-9. PubMed ID: 14521791
[TBL] [Abstract][Full Text] [Related]
17. [Results of active preventive vaccination against hepatitis B with a German vaccine].
Henning H; Laufs R; Kätzner K; Bredehorst R
Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
[TBL] [Abstract][Full Text] [Related]
18. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.
Purcell RH; Gerin JL
Am J Med Sci; 1975; 270(2):395-9. PubMed ID: 828832
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
